0001783328-21-000001.txt : 20210128 0001783328-21-000001.hdr.sgml : 20210128 20210128093622 ACCESSION NUMBER: 0001783328-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210128 DATE AS OF CHANGE: 20210128 EFFECTIVENESS DATE: 20210128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-387638 FILM NUMBER: 21562362 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: SUITE 1555 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: (617) 351-2590 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: SUITE 1555 CITY: BOSTON STATE: MA ZIP: 02199 D 1 primary_doc.xml X0708 D LIVE 0001783328 TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 857-399-9500 DELAWARE T-Scan Therapeutics, Inc. None Corporation true 2018 David Southwell c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Director Christoph Westphal c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Nandita Shangari c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Andrew Hedin c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Timothy Barberich c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Ittai Harel c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Doug Fambrough c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Brian Silver c/o TScan Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2021-01-15 false true false 0 100000000 100000000 0 false 16 0 0 0 false TScan Therapeutics, Inc. David Southwell David Southwell Chief Executive Officer 2021-01-28